Cargando…

Development and validation of a prognostic model for patients with hepatorenal syndrome: A retrospective cohort study

BACKGROUND: Hepatorenal syndrome (HRS) is a severe complication of cirrhosis with high mortality, which necessitates accurate clinical decision. However, studies on prognostic factors and scoring systems to predict overall survival of HRS are not enough. Meanwhile, a multicenter cohort study with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Xin-Yu, Lin, Fei-Yan, Wu, Jian, Cao, Hong-Cui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160623/
https://www.ncbi.nlm.nih.gov/pubmed/34092979
http://dx.doi.org/10.3748/wjg.v27.i20.2615
_version_ 1783700321698054144
author Sheng, Xin-Yu
Lin, Fei-Yan
Wu, Jian
Cao, Hong-Cui
author_facet Sheng, Xin-Yu
Lin, Fei-Yan
Wu, Jian
Cao, Hong-Cui
author_sort Sheng, Xin-Yu
collection PubMed
description BACKGROUND: Hepatorenal syndrome (HRS) is a severe complication of cirrhosis with high mortality, which necessitates accurate clinical decision. However, studies on prognostic factors and scoring systems to predict overall survival of HRS are not enough. Meanwhile, a multicenter cohort study with a long span of time could be more convincing. AIM: To develop a novel and effective prognostic model for patients with HRS and clarify new prognostic factors. METHODS: We retrospectively enrolled 1667 patients from four hospitals, and 371 eligible patients were finally analyzed to develop and validate a novel prognostic model for patients with HRS. Characteristics were compared between survivors and non-survivors, and potential prognostic factors were selected according to the impact on 28-d mortality. Accuracy in predicting 28-d mortality was compared between the novel and other scoring systems, including Model for End-Stage Liver Disease (MELD), Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA), and Chinese Group on the Study of Severe Hepatitis B-Acute-on-Chronic Liver Failure (COSSH-ACLF). RESULTS: Five prognostic factors, comprised of gender, international normalized ratio, mean corpuscular hemoglobin concentration, neutrophil percentage, and stage, were integrated into a new score, GIMNS; stage is a binary variable defined by the number of failed organs. GIMNS was positively correlated with MELD, CLIF-SOFA, and COSSH-ACLF. Additionally, it had better accuracy [area under the receiver operating characteristic curve (AUROC): 0.830] than MELD (AUROC: 0.759), CLIF-SOFA (AUROC: 0.767), and COSSH-ACLF (AUROC: 0.759) in the derivation cohort (P < 0.05). It performed better than MELD and CLIF-SOFA in the validation cohort (P < 0.050) and had a higher AUROC than COSSH-ACLF (P = 0.122). CONCLUSION: We have developed a new scoring system, GIMNS, to predict 28-d mortality of HRS patients. Mean corpuscular hemoglobin concentration and stage were first proposed and found to be related to the mortality of HRS. Additionally, the GIMNS score showed better accuracy than MELD and CLIF-SOFA, and the AUROC was higher than that of COSSH-ACLF.
format Online
Article
Text
id pubmed-8160623
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-81606232021-06-03 Development and validation of a prognostic model for patients with hepatorenal syndrome: A retrospective cohort study Sheng, Xin-Yu Lin, Fei-Yan Wu, Jian Cao, Hong-Cui World J Gastroenterol Retrospective Cohort Study BACKGROUND: Hepatorenal syndrome (HRS) is a severe complication of cirrhosis with high mortality, which necessitates accurate clinical decision. However, studies on prognostic factors and scoring systems to predict overall survival of HRS are not enough. Meanwhile, a multicenter cohort study with a long span of time could be more convincing. AIM: To develop a novel and effective prognostic model for patients with HRS and clarify new prognostic factors. METHODS: We retrospectively enrolled 1667 patients from four hospitals, and 371 eligible patients were finally analyzed to develop and validate a novel prognostic model for patients with HRS. Characteristics were compared between survivors and non-survivors, and potential prognostic factors were selected according to the impact on 28-d mortality. Accuracy in predicting 28-d mortality was compared between the novel and other scoring systems, including Model for End-Stage Liver Disease (MELD), Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA), and Chinese Group on the Study of Severe Hepatitis B-Acute-on-Chronic Liver Failure (COSSH-ACLF). RESULTS: Five prognostic factors, comprised of gender, international normalized ratio, mean corpuscular hemoglobin concentration, neutrophil percentage, and stage, were integrated into a new score, GIMNS; stage is a binary variable defined by the number of failed organs. GIMNS was positively correlated with MELD, CLIF-SOFA, and COSSH-ACLF. Additionally, it had better accuracy [area under the receiver operating characteristic curve (AUROC): 0.830] than MELD (AUROC: 0.759), CLIF-SOFA (AUROC: 0.767), and COSSH-ACLF (AUROC: 0.759) in the derivation cohort (P < 0.05). It performed better than MELD and CLIF-SOFA in the validation cohort (P < 0.050) and had a higher AUROC than COSSH-ACLF (P = 0.122). CONCLUSION: We have developed a new scoring system, GIMNS, to predict 28-d mortality of HRS patients. Mean corpuscular hemoglobin concentration and stage were first proposed and found to be related to the mortality of HRS. Additionally, the GIMNS score showed better accuracy than MELD and CLIF-SOFA, and the AUROC was higher than that of COSSH-ACLF. Baishideng Publishing Group Inc 2021-05-28 2021-05-28 /pmc/articles/PMC8160623/ /pubmed/34092979 http://dx.doi.org/10.3748/wjg.v27.i20.2615 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Cohort Study
Sheng, Xin-Yu
Lin, Fei-Yan
Wu, Jian
Cao, Hong-Cui
Development and validation of a prognostic model for patients with hepatorenal syndrome: A retrospective cohort study
title Development and validation of a prognostic model for patients with hepatorenal syndrome: A retrospective cohort study
title_full Development and validation of a prognostic model for patients with hepatorenal syndrome: A retrospective cohort study
title_fullStr Development and validation of a prognostic model for patients with hepatorenal syndrome: A retrospective cohort study
title_full_unstemmed Development and validation of a prognostic model for patients with hepatorenal syndrome: A retrospective cohort study
title_short Development and validation of a prognostic model for patients with hepatorenal syndrome: A retrospective cohort study
title_sort development and validation of a prognostic model for patients with hepatorenal syndrome: a retrospective cohort study
topic Retrospective Cohort Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160623/
https://www.ncbi.nlm.nih.gov/pubmed/34092979
http://dx.doi.org/10.3748/wjg.v27.i20.2615
work_keys_str_mv AT shengxinyu developmentandvalidationofaprognosticmodelforpatientswithhepatorenalsyndromearetrospectivecohortstudy
AT linfeiyan developmentandvalidationofaprognosticmodelforpatientswithhepatorenalsyndromearetrospectivecohortstudy
AT wujian developmentandvalidationofaprognosticmodelforpatientswithhepatorenalsyndromearetrospectivecohortstudy
AT caohongcui developmentandvalidationofaprognosticmodelforpatientswithhepatorenalsyndromearetrospectivecohortstudy